12- Sella EM, Sato EI, Leite WA, Oliveira Filho JA, Barbieri A. Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus. Ann Rheum Dis. 2003 Nov;62(11):1066-70.
13- Moser KW, O'Keefe JH Jr, Bateman TM, McGhie IA. Coronary calcium screening in asymptomatic patients as a guide to risk factor modification and stress myocardial perfusion imaging. J Nucl Cardiol. 2003 Nov-Dec;10(6):590-8. Comment in: J Nucl Cardiol. 2003 Nov-Dec;10(6):692-5.
14- Coma-Canella I, Martinez-Caro D, Cosin-Sales J, Fernandez-Jarne E, Garcia Velloso MJ, Giménez M. Clandestine ischemia in patients with vasospastic angina. Coron Artery Dis. 2000 Jul;11(5):383-90.
15- Candell-Riera J, Santana-Boado C, Bermejo B, Castell-Conesa J, Aguade-Bruix S, Canela T, Soler-Soler J. Prognosis of "clandestine" myocardial ischemia, silent myocardial ischemia, and angina pectoris in medically treated patients.Am J Cardiol. 1998 Dec 1;82(11):1333-8.
16- Eber B, Lind P, Dusleag J, Langsteger W, Eber O, Klein W. [Tl-201 myocardial SPECT in silent myocardial ischemia and angiographically proven coronary heart disease]. Wien Klin Wochenschr. 1989 Sep 15;101(17):574-9.
17- Williams KA, Taillon LA, Carter JE Jr. Asymptomatic and electrically silent myocardial ischemia during upright leg cycle ergometry and treadmill exercise (clandestine myocardial ischemia). Am J Cardiol. 1993 Nov 15;72(15):1114-20.
18- Valensi P, Paries J, Brulport-Cerisier V, Torremocha F, Sachs RN, Vanzetto G, Cosson E, Lormeau B, Attali JR, Marechaud R, Estour B, Halimi S. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care. 2005 Nov;28(11):2722-7.
19- Noble GL, Heller GV. Single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes. Curr Cardiol Rep. 2005 Mar;7(2):117-23.
20- Acampa W, Spinelli L, Petretta M, De Lauro F, Ibello F, Cuocolo A. Prognostic value of myocardial ischemia in patients with uncomplicated acute myocardial infarction: direct comparison of stress echocardiography and myocardial perfusion imaging. J Nucl Med. 2005 Mar;46(3):417-23.
21- Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, Shaw LJ, Amanullah AM, Germano G, Hachamovitch R. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003 Apr 2;41(7):1125-33.
22- Vázquez-Mellado J, García CG, Vázquez SG, Medrano G, Ornelas M, Alcocer L, Marquez A, Burgos-Vargas R. Metabolic Syndrome and Ischemic Heart Disease in Gout. J Clin Rheumatol. 2004 Jun;10(3):105-109.
23- Rochela Vázquez, Luis Manuel, Dr. et al. Correlación de los resultados del SPECT de Perfusión Miocárdica con 99mTc-MIBI con la presencia de Factores Mayores de Riesgo Aterosclerótico, en pacientes 40 años de edad (resultados preliminares). Journal 10 (41): July 2008. Article N° AJ41-3. http://www.alasbimnjournal.cl/
24- Shaw LJ, Berman DS, Hendel RC, Alazraki N, Krawczynska E, Borges-Neto S, Maddahi J, Cerqueira M. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol. 2006 May 15;97(10):1538-44. Epub 2006 Apr 3.
25- Wong ND, Rozanski A, Gransar H, Miranda-Peats R, Kang X, Hayes S, Shaw L, Friedman J, Polk D, Berman DS. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care. 2005 Jun;28(6):1445-50.
26- Soman P, Dave DM, Udelson JE, Han H, Ouda HZ, Patel AR, Karas RH, Kuvin JT. Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease. J Nucl Cardiol. 2006 Nov;13(6):756-60.
27- Høilund-Carlsen PF, Johansen A, Christensen HW, Vach W, Møldrup M, Bartram P, Veje A, Haghfelt T. Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias. Eur Heart J. 2006 Jan;27(1):29-34. Epub 2005 Sep 23. Comment in: Eur Heart J. 2006 Jan;27(1):3-4. Eur Heart J. 2006 May;27(9):1127-8; author reply 1128-9.
28- Hoilund-Carlsen PF, Johansen A, Vach W, Christensen HW, Moldrup M, Haghfelt T. High probability of disease in angina pectoris patients: is clinical estimation reliable? Can J Cardiol. 2007 Jun;23(8):641-7.
29- Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Poldermans D. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. J Hypertens. 2003 Oct;21(10):1945-51.
30- Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Huurman A, Feringa HH, Poldermans D. Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms. Am J Cardiol. 2006 Sep 1;98(5):585-90. Epub 2006 Jun 30.